松瑞藥

-0.15 (-0.79%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

18.95474成交張數5.71本益比1.34股價淨值比7.83%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	52	44	14.9%	6.23	14.15	25.8%	22.3%	-1.3	-1.4
2026Q1	45	36	20.0%	3.96	11.66	6.4%	5.5%	-3.0	-3.2
2025Q4	42	38	9.6%	11.06	12.18	14.8%	12.6%	-1.0	-1.6
2025Q3	41	37	10.2%	10.62	11.89	13.9%	12.5%	1.0	0.9
2025Q2	41	36	11.7%	8.88	11.38	13.1%	11.5%	-0.5	-0.8
2025Q1	42	39	8.1%	17.96	12.27	13.6%	12.2%	0.3	-0.1
2024Q4	44	35	19.7%	4.71	11.05	5.3%	4.5%	1.4	0.9
2024Q3	38	35	9.0%	17.94	10.91	5.3%	4.8%	1.2	0.9
2024Q2	39	34	12.2%	12.67	10.77	3.6%	3.1%	1.2	1.1
2024Q1	39	34	11.7%	13.99	10.79	3.1%	2.5%	1.4	1.1
2023Q4	38	34	12.0%	12.67	10.56	0.9%	0.7%	1.0	1.0
2023Q3	37	33	11.1%	15.51	10.42	-1.6%	-1.4%	1.5	1.5
2023Q2	38	33	11.7%	13.89	10.47	2.9%	2.1%	1.1	1.0
2023Q1	43	34	21.9%	4.44	10.56	2.7%	2.0%	0.3	0.3
2022Q4	44	34	23.6%	3.98	10.57	1.1%	0.8%	0.1	0.1
2022Q3	44	34	23.2%	4.04	10.69	1.4%	1.1%	3.9	3.8
2022Q2	50	33	35.4%	2.56	10.27	-4.2%	-2.9%	0.7	0.5
2022Q1	46	33	29.0%	7.89	10.28	-3.7%	-2.6%	1.2	1.0
2021Q4	45	33	27.0%	9.76	10.45	0.3%	0.2%	0.1	-0.0
2021Q3	47	33	28.5%	6.13	10.54	4.0%	2.8%	0.5	0.4
2021Q2	48	34	28.4%	5.91	11.42	7.2%	4.8%	-1.3	-1.6
2021Q1	48	34	29.0%	5.52	11.36	8.3%	5.3%	-1.0	-1.3
2020Q4	48	33	31.1%	4.48	11.08	9.0%	5.7%	-0.7	-1.4
2020Q3	47	32	32.7%	4.39	10.66	7.5%	4.6%	0.9	0.6
2020Q2	50	30	39.2%	3.44	10.26	6.4%	3.5%	0.7	0.2
2020Q1	43	23	45.9%	1.36	8.63	4.8%	2.5%	-0.1	-0.7
2019Q4	40	22	45.1%	1.32	8.26	-0.2%	-0.1%	0.9	0.2
2019Q3	41	22	46.6%	1.30	8.10	-7.7%	-4.1%	0.9	0.3
2019Q2	39	19	51.7%	1.10	7.63	-13.0%	-6.8%	1.6	1.2
2019Q1	39	18	52.2%	1.96	7.43	-14.1%	-7.5%	-1.8	-2.2
2018Q4	35	19	47.4%	1.90	7.48	-17.9%	-9.6%	1.1	0.8
2018Q3	36	20	46.0%	2.06	7.92	-14.4%	-8.2%	-1.4	-1.8
2018Q2	36	21	43.3%	2.37	8.30	-8.8%	-4.8%	0.2	-0.4
2018Q1	35	21	40.6%	3.14	8.38	-4.2%	-2.6%	-1.8	-2.5
2017Q4	39	22	45.2%	2.22	8.77	1.0%	0.6%	0.8	0.5
2017Q3	37	22	39.4%	4.10	8.98	4.4%	2.7%	0.9	0.4
2017Q2	41	22	46.5%	4.01	8.90	1.4%	0.8%	1.2	0.9
2017Q1	34	21	37.7%	3.83	8.66	-4.3%	-2.4%	-0.3	-0.6
2016Q4	34	21	38.3%	2.07	8.60	–	–	0.9	0.8
2016Q3	34	21	38.8%	1.78	8.49	–	–	-0.3	-0.5